Original Research
Published on 11 Nov 2013
A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor
in Pharmacogenetics and Pharmacogenomics
- 7,818 views
- 62 citations